Loading...
XSHE300642
Market cap323mUSD
Dec 31, Last price  
14.12CNY
1D
-1.96%
1Q
-2.56%
IPO
-31.63%
Name

Tellgen Corp

Chart & Performance

D1W1MN
XSHE:300642 chart
P/E
25.75
P/S
4.24
EPS
0.55
Div Yield, %
0.00%
Shrs. gr., 5y
0.10%
Rev. gr., 5y
8.27%
Revenues
543m
-24.19%
48,710,54076,828,379118,200,965169,382,003231,217,644302,888,219364,846,388441,452,526489,580,919654,588,606715,970,892542,809,310
Net income
89m
-28.34%
13,618,10922,576,48036,003,23665,778,55397,765,499126,814,971141,690,851157,018,318120,552,785161,082,764124,757,66689,403,542
CFO
142m
-13.77%
6,850,50026,329,10040,808,99864,668,23198,421,152105,997,332161,317,879174,843,00796,833,97182,613,509164,719,466142,045,487
Dividend
May 23, 20240.15 CNY/sh
Earnings
May 14, 2025

Profile

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
URL
https://www.tellgen.com/
IPO date
Apr 21, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
542,809
-24.19%
715,971
9.38%
Cost of revenue
450,420
590,633
Unusual Expense (Income)
NOPBT
92,389
125,338
NOPBT Margin
17.02%
17.51%
Operating Taxes
2,787
6,916
Tax Rate
3.02%
5.52%
NOPAT
89,602
118,423
Net income
89,404
-28.34%
124,758
-22.55%
Dividends
(40,717)
Dividend yield
1.20%
Proceeds from repurchase of equity
(3,391)
(10,000)
BB yield
0.12%
0.30%
Debt
Debt current
344
14,283
Long-term debt
11,358
15,292
Deferred revenue
5,789
Other long-term liabilities
6,560
Net debt
(663,511)
(474,786)
Cash flow
Cash from operating activities
142,045
164,719
CAPEX
(101,260)
Cash from investing activities
42,634
Cash from financing activities
(30,983)
FCF
173,629
111,175
Balance
Cash
492,330
504,360
Long term investments
182,884
Excess cash
648,073
468,562
Stockholders' equity
968,811
987,260
Invested Capital
900,214
1,033,001
ROIC
9.27%
11.71%
ROCE
5.97%
8.33%
EV
Common stock shares outstanding
163,145
162,561
Price
17.65
-15.10%
20.79
-34.44%
Market cap
2,879,512
-14.80%
3,379,639
-35.16%
EV
2,223,191
2,913,108
EBITDA
170,551
206,104
EV/EBITDA
13.04
14.13
Interest
726
741
Interest/NOPBT
0.79%
0.59%